08:50 AM BST, France - PMI Data for December:
- HCOB France Manufacturing PMI: actual 50.7; forecast 50.6; previous 47.8;
08:55 AM BST, Germany - PMI Data for December:
- HCOB Germany Manufacturing PMI: actual 47.0; forecast 47.7; previous 48.2;
09:00 AM BST, Euro Zone - PMI Data for December:
- HCOB Eurozone Manufacturing PMI: actual 48.8; forecast 49.2; previous 49.6;
The euro area PMI weakened stronger than expected as production fell for the first time from Februrary 2025, driven by a sharp deterioration in demand, especially exports. New orders declined faster, prompting deeper cuts to purchasing, inventories and employment. Supply chains tightened and input costs rose, yet firms kept discounting prices. Despite current weakness, business optimism jumped to multi-year highs.
Contrasting changes in France and Germany
France was one of the bright spots of the report, with its PMI rebound driven by a sharp pickup in export demand, helping stabilise output and soften the decline in overall orders. Employment returned to growth, inventories were run down, and purchasing cuts eased. Cost pressures moderated, enabling modest price rises, while domestic demand and political uncertainty capped confidence
Germany’s PMI fell as demand weakened further, led by a sharp acceleration in export order declines. Output slipped after a long expansion, prompting deeper cuts to jobs, purchasing and inventories. Supply bottlenecks and rising input costs added pressure, while intense competition forced further price discounting despite higher costs.
EURUSD (D1)
EURUSD extended its losses following the data release after earlier failing near key resistance around 1.1765. The pair has fallen roughly 0.5% over the past week, reflecting broader dollar strength amid more restrained US rate-cut expectations for Q1 2026. Immediate support sits near 1.1720, while a near-oversold RSI (approaching 30) should spark caution before chasing further downside.
Source: xStation5
Daily Summary: As a ceasefire drifts away, markets lose ground
Warsh before the Senate: βI will not be a tool of the presidentβ and signals Fed reform agenda
US Open: Macro Up, Tensions Down!
Defense sector earnings: RTX, Thales and Northrop Grumman
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
